Hydrocortisone 2.5% / Levocetirizine Dihydrochloride 2%
FDA Label NDC 72934-2113

The following Structured Product Label (SPL) was submitted to the FDA by Sincerus Florida, Llc for the product Hydrocortisone 2.5% / Levocetirizine Dihydrochloride 2% (NDC 72934-2113). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding directions for use, sincerus florida, llc. adverse reactions, active, inactive, ndc 72934- 2113-2 hydrocortisone 2.5% / levocetirizine dihydrochloride 2%. gel 30gm., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.